MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4

被引:123
|
作者
Zhang, Li [1 ]
Li, Ya-Jian [1 ]
Wu, Xun-Yi [2 ]
Hong, Zhen [2 ]
Wei, Wen-Shi [1 ]
机构
[1] Fudan Univ, Dept Neurol, Huadong Hosp, Shanghai 200040, Peoples R China
[2] Fudan Univ, Inst Neurol, Huashan Hosp, Shanghai 200040, Peoples R China
基金
美国国家科学基金会;
关键词
hypoxia; microglial activation; miR-181c; neuroinflammation; TLR4; NECROSIS-FACTOR-ALPHA; NEURODEGENERATIVE DISEASES; MESSENGER-RNA; ACTIVATION; DROSOPHILA; GENE; APOPTOSIS; CYTOKINES; SICKNESS; FAMILY;
D O I
10.1111/jnc.13021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cerebral hypoxia/ischemia rapidly induces inflammation in the brain, which is characterized by microglial activation and the release of inflammatory cytokines. We have previously demonstrated that miR-181c can directly regulate tumor necrosis factor (TNF)-alpha production post-transcriptionally. Here, we determined that hypoxia up-regulated TLR4 expression but down-regulated miR-181c expression in primary microglia. We also demonstrated that miR-181c suppresses TLR4 by directly binding its 30-untranslated region. In addition, miR-181c inhibited NF-jB activation and the downstream production of proinflammatory mediators, such as TNF-alpha, IL1b, and iNOS. Knocking down TLR4 in microglia significantly decreased TLR4 expression and inhibited NF-jB activation and the downstream production of proinflammatory mediators, whereas ectopic TLR4 expression significantly abrogated the suppressed inflammatory response induced by miR-181c. Therefore, our study identified an important role for the miR-181c-TLR4 pathway in hypoxic microglial activation and neuroinflammation. This pathway could represent a potential therapeutic target for cerebral hypoxic diseases associated with microglial activation and the inflammatory response.
引用
收藏
页码:713 / 723
页数:11
相关论文
共 50 条
  • [21] Toll-like receptor 4 signaling regulates the acute local inflammatory response to injury and the fibrosis/neovascularization of sterile wounds
    Brancato, Samielle K.
    Thomay, Alan A.
    Daley, Jean M.
    Crane, Meredith J.
    Reichner, Jonathan S.
    Sabo, Edmond
    Albina, Jorge E.
    WOUND REPAIR AND REGENERATION, 2013, 21 (04) : 624 - 633
  • [22] Intracellular osteopontin negatively regulates toll-like receptor 4-mediated inflammatory response via regulating GSK3β and 4EBP1 phosphorylation
    Yang, Haiou
    Ye, Xingchen
    Zhang, Xiaoqing
    Li, Xiaoliang
    Fu, Qihua
    Tang, Zhenhua
    CYTOKINE, 2018, 108 : 89 - +
  • [23] SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
    Tenazoa Wong, Deysi Viviana
    Ribeiro-Filho, Helder Veras
    Souza Wanderley, Carlos Wagner
    Vitorino Goncalves Leite, Caio Abner
    Lima, Jonilson Berlink
    Brigido Assef, Alexia Nathalia
    Cajado, Aurilene Gomes
    Ponte Batista, Gabriela Loiola
    Gonzalez, Rafael Holanda
    Silva, Karla Oliveira
    Carvalho Borges, Luis Philipi
    Nunes Alencar, Nylane Maria
    Wilke, Diego Veras
    Cunha, Thiago Mattar
    Migliorini Figueira, Ana Carolina
    Cunha, Fernando Queiroz
    Pereira Lima-Junior, Roberto Cesar
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) : 287 - 298
  • [24] SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
    Deysi Viviana Tenazoa Wong
    Helder Veras Ribeiro-Filho
    Carlos Wagner Souza Wanderley
    Caio Abner Vitorino Gonçalves Leite
    Jonilson Berlink Lima
    Alexia Nathália Brígido Assef
    Aurilene Gomes Cajado
    Gabriela Loiola Ponte Batista
    Rafael Holanda González
    Karla Oliveira Silva
    Luis Philipi Carvalho Borges
    Nylane Maria Nunes Alencar
    Diego Veras Wilke
    Thiago Mattar Cunha
    Ana Carolina Migliorini Figueira
    Fernando Queiroz Cunha
    Roberto César Pereira Lima-Júnior
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 287 - 298
  • [25] Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury
    Robertson, Sarah A.
    Hutchinson, Mark R.
    Rice, Kenner C.
    Chin, Peck-Yin
    Moldenhauer, Lachlan M.
    Stark, Michael J.
    Olson, David M.
    Keelan, Jeffrey A.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (04)
  • [26] Toll-like receptor 4 mediates oxidant-induced inflammatory response in macrophages
    Wang, M
    Ao, L
    Cha, J
    Meng, X
    SHOCK, 2004, 21 : 20 - 20
  • [27] Disabled-2 negatively regulates lipopolysaccharide-stimulated Toll-like receptor 4 signaling and inflammation response in murine macrophage
    Hung, Wei-Shan
    Chou, Chein-Shen
    Tseng, Ching-Ping
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [28] Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response
    Butchar, Jonathan P.
    Parsa, Kishore V. L.
    Marsh, Clay B.
    Tridandapani, Susheela
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (32) : 4143 - 4153
  • [29] Toll-Like Receptor 4 Stimulation Initiates an Inflammatory Response That Decreases Cardiomyocyte Contractility
    Avlas, Orna
    Fallach, Reut
    Shainberg, Asher
    Porat, Eyal
    Hochhauser, Edith
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (07) : 1895 - 1909
  • [30] TOLL-LIKE RECEPTOR 2 NEGATIVELY REGULATES FCγ RECEPTOR RESPONSE IN MACROPHAGES AND INHIBITS FCγR-MEDIATED ARTHRITIS
    Abdollahi-Roodsaz, Shahla
    Koenders, Marije I.
    van Lent, Peter L.
    van de Loo, Fons A.
    van den Berg, Wim B.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A36 - A36